Background: While the incidence of calcium urolithiasis increases, the precise mechanism of calcium oxalate stone formation is still controversial. Is the composition of a recurrent calcium oxalate stones always the same as previous ones? There are few reports that specifically address the question by study of sequential changes of the composition of recurrent calcium calculi. Method

Background : Although many factors have been reported as predictors of the recurrence of renal cell carcinoma (RCC), none of the factors are consistent among different studies. In the study presented here, the potential clinicopathological predictors of the recurrence of N0M0 RCC were examined. Methods : A total of 201 patients who underwent nephrectomy for N0M0 RCC were examined to determine the pathological tumor stage (pT stage), pathological tumor grade of malignancy (tumor grade), symptoms, and tumor size.Results : RCC recurred in 29 patients (14.4%), 50% of whom developed new tumors within 24 months after nephrectomy. The disease-free 3-and 10-year survival rates declined as the pT stage and tumor grade increased: these rates were, respectively, 98.6% and 86.5% for pT1a; 93.7% and 87.9% for pT1b; 100% and 100% for pT2; 78.6% and 58.0% for pT3a; and 88.9% and 16.7% for pT3b. Significant differences in the recurrence rate were noted between pT3 and pT1 or pT2, as well as between grade 3 disease and grade 1 or grade 2 tumors. Multivariate analysis showed that a combination of the pT stage, grade, and presence of symptoms was useful for predicting the recurrence of RCC. Conclusion : The present study showed that patients undergoing nephrectomy for N0M0 RCC should be followed-up carefully for 2 years postoperatively with special attention to high pT stage, high grade, and the development of symptoms.

Nucleolar organizer regions (NORs) were studied in surgically removed specimens from 76 patients with squamous cell carcinomas of the larynx using an argyrophilic (Ag) staining technique. The mean number of AgNORs per nucleus was 4.3 +/- 1.38 (SD). The mean AgNOR number for T1 or T2 disease was statistically lower than that for T3 or T4 lesions (P < 0.05). The mean AgNOR number was lower in patients with N0 disease than in patients with N1 or N2 or N3 tumors (P < 0.05). There was also a statistically significant difference between the mean AgNOR number for stage II and stage III disease (P < 0.01), for stage III and stage IV disease (P < 0.05), but not for stage I and stage II disease. According to the histological grading, there was a significant difference between the mean AgNOR number for the well-differentiated and moderately differentiated tumors (P < 0.05), and for the moderately differentiated and poorly differentiated types (P < 0.01). These results suggest that the number of AgNORs in the nucleus is a significant indicator of laryngeal carcinomas.

No abstract

No abstract